tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mark Marcon, 96 are a BUY (63.58%), 55 are a HOLD (36.42%).
Analyst Mark Marcon, currently employed at BAIRD, carries an average stock price target met ratio of 56.87% that have a potential upside of 19.11% achieved within 212 days.
Mark Marcon’s has documented 316 price targets and ratings displayed on 20 stocks. The coverage is on Healthcare, Industrials, Technology sectors.
Most recent stock forecast was given on AMN, AMN Healthcare Services at 20-Feb-2026.
Analyst best performing recommendations are on HQY (HEALTHEQUITY).
The best stock recommendation documented was for HQY (HEALTHEQUITY) at 3/18/2020. The price target of $47 was fulfilled within 6 days with a profit of $6.46 (15.93%) receiving and performance score of 26.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Mar-2022
$110
$33.51 (43.81%)
$130
14 days ago
(18-Feb-2026)
2/7 (28.57%)
$35.64 (47.93%)
558
Buy Since 07-Sep-2022
$110
$33.51 (43.81%)
$134
14 days ago
(18-Feb-2026)
10/13 (76.92%)
$35.64 (47.93%)
372
Sell Since 09-Jan-2026
$89
$12.51 (16.36%)
$104
1 months 23 days ago
(09-Jan-2026)
4/4 (100%)
$-5.15 (-5.47%)
34
Buy Since 01-Jul-2021
$125
$48.51 (63.42%)
$120
1 months 24 days ago
(08-Jan-2026)
10/12 (83.33%)
$26.49 (26.89%)
318
Buy Since 05-Jun-2019
$129
$52.51 (68.65%)
$126
3 months ago
(04-Dec-2025)
9/13 (69.23%)
$33.33 (34.84%)
114
Which stock is Mark Marcon is most bullish on?
What Year was the first public recommendation made by Mark Marcon?
